Hepatitis A is a vaccine-preventable infection caused by the hepatitis A virus (HAV). Over
150 million new infections of hepatitis A occur annually. HAV causes an acute inflammatory …

Non-alcoholic fatty liver disease (NAFLD), specifically its progressive form non-alcoholic
steatohepatitis (NASH), represents the fastest growing indication for liver transplantation in …

Abstract Background and Aims In patients with NAFLD, those with type 2 diabetes mellitus
(DM) have a high risk of progression to HCC. However, the determinants of HCC risk in …

There is much controversy regarding enhanced recovery for recipients of liver transplants
from deceased and living donors. The objectives of this Review were to summarise current …

Conclusions Compared with nonfrail patients, frail LT recipients had a higher risk of post‐LT
death and greater post‐LT health care utilization, although overall post‐LT survival was …

Liver transplantation (LT) is the treatment of choice for liver failure and selected cases of
malignancies. Transplantation activity has increased over the years, and indications for LT …

Background. The impaired physical fitness of end-stage liver disease patients often persists
after liver transplantation (LT) and compromises posttransplant recovery. This systematic …

Ischemia–reperfusion injury (IRI) remains as a critical challenge for organ transplantation.
Herein, an enzyme therapeutic based on superoxide dismutase and catalase for effective …

Frailty, nutritional status, and body composition are increasingly under the spotlight of
interest in various clinical scenarios including liver transplantation. To address the rapidly …

Background Liver transplantation has become increasingly common as a last-resort
treatment for end-stage liver diseases and liver cancer, with continually improving success …